Ketoprofen

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ibuprofen. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes indomethacin. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes isopropamide iodide. It belongs to antispasmodic / anti ulcer category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes isosorbide dinitrato. It belongs to antianginal category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes isosorbide mononitrato. It belongs to antianginal category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes KCI. It belongs to K deficiency category. Bulk physical form: pellets, microcapsules. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes lansoprazolo. It belongs to antiulerative category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes mebeverine HCI. It belongs to antispasmodic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes meclozine. It belongs to anti emetic / antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes naftohydrofuryl oxalate. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nicardipina. It belongs to antianginal / antihypertensive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nifedipine. It belongs to antianginal / antihypertensive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.